Omar Niss, MD

Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemia. Niss, O; Morin, CE; Hashemi, S; Alsaied, T; Lang, SM; Taylor, MD; Tasset, M; Malik, P; Quinn, CT. Blood Red Cells Iron. 2025; 1(3).

A New First-Line Option for Pediatric ITP-Incremental Progress or Paradigm Shift? Niss, O; Ware, RE; Quinn, CT. Journal of the American Medical Association (JAMA). 2025; 334(20):1802-1803.

Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial. Jan, S; Steinway, C; Belton, T; Shults, J; Bennett, L; Teng, O; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Andemariam, B; Mulchan, SS; Rubin, D; Smith-Whitley, K. JAMA Network Open. 2025; 8(11):e2543571.

Reassessing voxelotor safety and efficacy: Real-world outcomes from the ASH research collaborative data hub. Niss, O; Fenchel, M; Abrams, C; Quinn, C; Kutlar, A. Blood. 2025; 146(Supplement 1):6226-6226.

Impact of disease genotype and severity of anemia on myocardial extracellular volume fraction in sickle cell disease (SCD) and non-SCD hemolytic anemias. Niss, O; Morin, C; Hashemi, S; Alsaied, T; Lang, S; Tasset, M; Taylor, M; Malik, P; Quinn, C. Blood. 2025; 146(Supplement 1):2957.

Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America. Hamdan, L; Elgammal, Y; Husami, A; Meznarich, J; Fasipe, F; Chonat, S; Mclemore, M; Schwartz, J; Sahib, S; Mccavit, T; Zhang, W; Lorsbach, R; Niss, O; Kalfa, T. Blood. 2025; 146(Supplement 1):4685-4685.

Biomarkers of ineffective erythropoiesis in patients with transfusion- dependent thalassemia. Hamdan, L; Elgammal, Y; Shova, A; Aygun, B; Quinn, C; Niss, O; Kalfa, T. Blood. 2025; 146(Supplement 1):4684-4684.

Biomarkers of ineffective erythropoiesis in patients with sickle cell anemia, at baseline and while treated with hydroxyurea, in comparison to patients with other iron-loading red cell disorders. Elgammal, Y; Hamdan, L; Risinger, M; Kostantinidis, D; Seu, K; Mcelhinney, K; Niss, O; Nemeth, E; Quinn, C; Ware, R; Kalfa, T. Blood. 2025; 146(Supplement 1):4686.

The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial. Belton, TD; Steinway, CM; Teng, O; Shults, J; Barakat, LP; Aygun, B; Appiah-Kubi, A; Crosby, LE; Niss, O; Andemariam, B; Johnson, TB; Rubin, DM; Smith-Whitley, KM; Jan, S. JMIR Research Protocols. 2025; 14:e69239.

Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial. Grimley, M; Davies, SM; Shrestha, A; Shova, A; Asnani, M; Kent, M; Sayani, F; Quinn, CT; Niss, O; Lutzko, C; Witting, S; Latham, T; Bushman, FD; Malik, P. Nature Medicine. 2025; 31(7):2204-2212.